Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers
暂无分享,去创建一个
C. Kung | Hua Yang | M. Goldwasser | B. Silver | Zheng Yuan | S. Agresta | L. Silverman | P. Kosinski | A. Barbier | Marvin B. Cohen | R. Goldwater | Yue Chen | E. Merica